Co-Diagnostics, a molecular diagnostics company, will participate in three major global tuberculosis events in November 2026, held in Bali and Rio de Janeiro. These events focus on advancing TB diagnosis, treatment, and prevention. The company's joint venture in India, CoSara Diagnostics, is preparing to commercially launch its CoSara PCR Mycobacterium tuberculosis test, aiming to expand access to rapid and decentralized TB testing in the country with the highest TB burden. Regulatory clearance in India is anticipated by the fourth quarter of 2026, with commercial sales expected to begin before year-end.
Co-Diagnostics' upcoming participation in global tuberculosis events provides context for health sector trends. Of 150 priced health-sector US stocks on Pluang, 87 rose and 56 fell today. Notable movers include Novavax Inc (NVAX) at USD 11.21 with a 5.31% increase and a typical hold time of 60 days, as of Nov 05, 2026 19:42 WIB.
Scout Clean Energy has announced that its 183 MW Nimbus Wind Farm in Carroll County, Arkansas, is now commercially operational after two years of construction. The wind farm, the largest in Arkansas, generates enough electricity to power over 40,000 ...
CRCAM Toulouse 31 announced the publication and filing of its financial information report for the quarter ending September 30, 2026. The report is accessible to the public on the company's website under the regulatory information section for 2026. T...
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
